Free Trial

Enzo Biochem (ENZ) Short Interest Ratio & Short Volume

Enzo Biochem logo
$1.14
0.00 (0.00%)
(As of 10/31/2024 ET)

Enzo Biochem Short Interest Data

Enzo Biochem (ENZ) has a short interest of 500,300 shares, representing 1.39% of the float (the number of shares available for trading by the public). This marks a -3.42% decrease in short interest from the previous month. The short interest ratio (days to cover) is 7.8, indicating that it would take 7.8 days of the average trading volume of 95,747 shares to cover all short positions.

Current Short Interest
500,300 shares
Previous Short Interest
518,000 shares
Change Vs. Previous Month
-3.42%
Dollar Volume Sold Short
$565,339.00
Short Interest Ratio
7.8 Days to Cover
Last Record Date
October 15, 2024
Outstanding Shares
51,458,000 shares
Float Size
35,920,000 shares
Short Percent of Float
1.39%
Today's Trading Volume
66,868 shares
Average Trading Volume
95,747 shares
Today's Volume Vs. Average
70%
Short Selling Enzo Biochem?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Enzo Biochem and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ENZ Short Interest Over Time

ENZ Days to Cover Over Time

ENZ Percentage of Float Shorted Over Time

Enzo Biochem Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/2024500,300 shares $565,339.00 -3.4%1.4%7.8 $1.13
9/30/2024518,000 shares $580,160.00 +8.2%1.4%6.9 $1.12
9/15/2024478,700 shares $531,357.00 -5.0%1.3%5.3 $1.11
8/31/2024504,000 shares $574,560.00 -0.8%1.4%5.1 $1.14
8/15/2024507,800 shares $563,658.00 -4.5%1.4%4.3 $1.11
7/31/2024531,800 shares $600,934.00 -10.1%1.5%4.4 $1.13
7/15/2024591,200 shares $691,704.00 -2.3%1.7%4.6 $1.17
6/30/2024605,300 shares $659,777.00 +8.0%1.7%4.6 $1.09
6/15/2024560,500 shares $650,180.00 -6.9%1.6%4.9 $1.16
5/31/2024602,300 shares $716,737.00 -0.2%1.7%5.4 $1.19
5/15/2024603,600 shares $663,960.00 -10.8%1.7%6.1 $1.10
4/30/2024676,700 shares $710,535.00 -7.2%1.9%6 $1.05
4/15/2024729,200 shares $845,872.00 +1.2%2.1%6.9 $1.16
3/31/2024720,600 shares $915,162.00 -1.7%2.0%7.6 $1.27
3/15/2024733,100 shares $901,713.00 +2.5%2.1%7.2 $1.23
2/29/2024715,400 shares $951,482.00 -9.8%2.1%6.3 $1.33
2/15/2024792,900 shares $1.07 million +5.1%2.3%7 $1.35
1/31/2024754,700 shares $950,922.00 -22.8%2.2%7.6 $1.26
1/15/2024978,000 shares $1.36 million -1.6%2.8%9.1 $1.39
12/31/2023994,000 shares $1.38 million -25.3%2.8%9.1 $1.39
12/15/20231,330,000 shares $1.77 million -14.7%3.8%11.8 $1.33
11/30/20231,560,000 shares $1.98 million -3.1%4.4%13.9 $1.27
11/15/20231,610,000 shares $1.98 million -9.0%4.6%13.1 $1.23
10/31/20231,770,000 shares $2.37 million -1.7%5.1%9.8 $1.34
10/15/20231,800,000 shares $2.57 million +0.6%5.2%6 $1.43
9/30/20231,790,000 shares $2.51 million +7.2%5.2%5.4 $1.40
9/15/20231,670,000 shares $2.17 million +13.6%4.8%5 $1.30
8/31/20231,470,000 shares $2.28 million -3.9%3.9%4.4 $1.55
8/15/20231,530,000 shares $2.42 million +5.5%4.0%4.8 $1.58
7/31/20231,450,000 shares $2.15 million +40.8%3.8%5.2 $1.48
7/15/20231,030,000 shares $1.37 million +20.8%3.1%6.5 $1.33
6/30/2023852,900 shares $1.57 million -10.6%2.6%5.3 $1.84
6/15/2023953,500 shares $1.95 million -12.5%2.9%4.8 $2.04
5/31/20231,090,000 shares $2.40 million -8.4%3.3%1.3 $2.20
5/15/20231,190,000 shares $2.83 million -2.5%3.6%1.4 $2.38
4/30/20231,220,000 shares $3.09 million +8.9%3.7%1.4 $2.53
4/15/20231,120,000 shares $2.84 million +8.7%3.4%1.3 $2.54
3/31/20231,030,000 shares $2.50 million +113.8%3.1%1.3 $2.43
3/15/2023481,800 shares $481,800.00 +49.2%1.3%0.6 $1.00
2/28/2023322,900 shares $364,877.00 -6.0%0.9%4.1 $1.13
The real reason Elon is fully endorsing Trump (Ad)

Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump.

Watch this new documentary and you’ll discover what Elon knows,
2/15/2023343,600 shares $439,808.00 -6.8%0.9%4.6 $1.28
1/31/2023368,700 shares $494,058.00 +6.1%1.0%5 $1.34
1/15/2023347,500 shares $528,200.00 +1.0%0.9%5.1 $1.52
12/30/2022344,100 shares $492,063.00 +9.1%1.0%5.2 $1.43
12/15/2022315,300 shares $365,748.00 -21.2%0.9%5.2 $1.16
11/30/2022400,300 shares $796,597.00 +2.4%1.1%8.5 $1.99
11/15/2022391,000 shares $871,930.00 -3.0%1.1%8.3 $2.23
10/31/2022403,100 shares $862,634.00 +5.9%1.1%8.5 $2.14
10/15/2022380,600 shares $806,872.00 -1.8%1.0%8.4 $2.12
9/30/2022387,400 shares $863,902.00 -14.8%1.0%8 $2.23
9/15/2022454,500 shares $1.03 million +12.1%1.2%7 $2.26
8/31/2022405,300 shares $980,826.00 -2.0%1.1%6.1 $2.42
8/15/2022413,400 shares $1.13 million -4.3%1.1%5.9 $2.73
7/31/2022431,900 shares $1.02 million -4.3%1.2%6.1 $2.37
7/15/2022451,400 shares $1.08 million -6.6%1.2%5.9 $2.40
6/30/2022483,300 shares $1.00 million -5.3%1.3%6.3 $2.07
6/15/2022510,200 shares $1.14 million +4.3%1.4%8.4 $2.23
5/31/2022489,300 shares $1.13 million -7.5%1.3%8.5 $2.31
5/15/2022528,900 shares $1.24 million +9.1%1.4%8.8 $2.35
4/30/2022484,800 shares $1.24 million -8.0%1.3%7.7 $2.55
4/15/2022527,000 shares $1.52 million -2.1%1.4%7.9 $2.88
3/31/2022538,500 shares $1.56 million -1.8%1.5%6.5 $2.90
3/15/2022548,300 shares $1.67 million -0.9%1.5%5.5 $3.04
2/28/2022553,200 shares $1.82 million -18.9%1.5%4.9 $3.29
2/15/2022682,400 shares $2.33 million -2.0%1.9%5.6 $3.41
1/31/2022696,100 shares $2.24 million -10.8%1.9%5.2 $3.22
1/15/2022780,700 shares $2.58 million +16.4%2.1%5.6 $3.31
12/31/2021670,900 shares $2.15 million +6.0%1.8%3.5 $3.21
12/15/2021633,000 shares $2.20 million -5.9%1.7%3.1 $3.48
11/30/2021672,600 shares $2.34 million +8.2%1.8%3.6 $3.48
11/15/2021621,900 shares $2.10 million +4.9%1.7%3.3 $3.38
10/29/2021592,700 shares $2.04 million +0.3%1.5%3.1 $3.44
10/15/2021590,700 shares $2.23 million -5.3%1.5%3 $3.78
9/30/2021623,700 shares $2.21 million +8.9%1.5%1.8 $3.54
9/15/2021572,500 shares $1.95 million -2.7%1.4%1.3 $3.40
8/31/2021588,200 shares $2.15 million -0.4%1.4%1.1 $3.66
8/13/2021590,400 shares $1.83 million -13.5%1.4%1 $3.10
7/30/2021682,300 shares $2.22 million -7.8%1.5%1.1 $3.26
7/15/2021739,700 shares $2.30 million -7.5%1.7%1.2 $3.11
6/30/2021800,000 shares $2.54 million -54.8%1.8%1.8 $3.17
6/15/20211,770,000 shares $5.31 million +7.9%4.0%5.1 $3.00
5/28/20211,640,000 shares $5.05 million +0.6%3.7%1.3 $3.08
5/14/20211,630,000 shares $4.82 million No Change3.7%1.4 $2.96
4/30/20211,630,000 shares $5.22 million +9.4%3.7%1.3 $3.20
4/15/20211,490,000 shares $5.01 million +8.8%3.4%1.2 $3.36
3/31/20211,370,000 shares $4.51 million -24.7%3.1%1.1 $3.29
3/15/20211,820,000 shares $5.21 million -3.7%4.1%1.5 $2.86
2/26/20211,890,000 shares $5.58 million -1.6%4.3%5.6 $2.95
2/12/20211,920,000 shares $6.28 million -1.0%4.4%5.7 $3.27
1/29/20211,940,000 shares $5.37 million -1.5%4.4%5.9 $2.77
The real reason Elon is fully endorsing Trump (Ad)

Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump.

Watch this new documentary and you’ll discover what Elon knows,
1/15/20211,970,000 shares $5.89 million +0.5%4.5%6.1 $2.99
12/31/20201,960,000 shares $5.12 million -1.0%4.4%6 $2.61
12/15/20201,980,000 shares $4.99 million +4.2%4.5%6.5 $2.52
11/30/20201,900,000 shares $3.86 million -2.1%4.3%6.3 $2.03
11/15/20201,940,000 shares $3.86 million -22.7%4.4%6.4 $1.99
10/30/20202,510,000 shares $4.92 million +9.1%5.7%8 $1.96
10/15/20202,300,000 shares $4.97 million +2.2%5.2%6.5 $2.16
9/30/20202,250,000 shares $4.75 million -3.0%5.1%4 $2.11
9/15/20202,320,000 shares $5.43 million +6.9%5.2%2.6 $2.34
8/31/20202,170,000 shares $4.62 million -3.1%4.9%2.4 $2.13
8/14/20202,240,000 shares $5.60 million -2.2%5.1%2.4 $2.50
7/31/20202,290,000 shares $5.45 million -7.3%5.2%2.3 $2.38
7/15/20202,470,000 shares $6.52 million +11.8%5.6%2.2 $2.64
6/30/20202,210,000 shares $4.95 million +18.2%5.0%2.4 $2.24
6/15/20201,870,000 shares $4.17 million -4.6%4.2%2.9 $2.23
5/29/20201,960,000 shares $5.64 million +3.7%4.5%2 $2.88
5/15/20201,890,000 shares $5.12 million +1.6%4.3%1.5 $2.71
4/30/20201,860,000 shares $5.62 million +10.1%4.2%1.6 $3.02
4/15/20201,690,000 shares $3.84 million +20.7%3.8%1.6 $2.27
3/31/20201,400,000 shares $3.50 million -1.9%3.2%1.6 $2.50
3/13/20201,426,600 shares $3.48 million +18.9%3.3%2.5 $2.44
2/28/20201,200,000 shares $2.77 million +9.1%2.7%2.1 $2.31
2/14/20201,100,000 shares $2.68 million +5.8%2.5%11.1 $2.44
1/31/20201,040,000 shares $2.32 million +19.5%2.4%11.5 $2.23
1/15/2020870,400 shares $1.99 million +3.0%2.0%10.7 $2.29
12/31/2019845,500 shares $2.19 million +0.9%1.9%10.6 $2.59

ENZ Short Interest - Frequently Asked Questions

What is Enzo Biochem's current short interest?

Short interest is the volume of Enzo Biochem shares that have been sold short but have not yet been closed out or covered. As of October 15th, investors have sold 500,300 shares of ENZ short. 1.39% of Enzo Biochem's shares are currently sold short. Learn More on Enzo Biochem's current short interest.

What is a good short interest ratio for Enzo Biochem?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ENZ shares currently have a short interest ratio of 8.0. Learn More on Enzo Biochem's short interest ratio.

What is a good short interest percentage for Enzo Biochem?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.39% of Enzo Biochem's floating shares are currently sold short.

Is Enzo Biochem's short interest increasing or decreasing?

Enzo Biochem saw a drop in short interest in October. As of October 15th, there was short interest totaling 500,300 shares, a drop of 3.4% from the previous total of 518,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Enzo Biochem's float size?

Enzo Biochem currently has issued a total of 51,458,000 shares. Some of Enzo Biochem's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Enzo Biochem currently has a public float of 35,920,000 shares.

How does Enzo Biochem's short interest compare to its competitors?

1.39% of Enzo Biochem's shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to Enzo Biochem: Sera Prognostics, Inc. (5.67%), LifeMD, Inc. (16.34%), Biodesix, Inc. (0.29%), Agape ATP Co. (2.99%), P3 Health Partners Inc. (1.79%), Quipt Home Medical Corp. (2.32%), EUDA Health Holdings Limited (0.02%), Ontrak, Inc. (8.33%), Exagen Inc. (0.29%), Concord Medical Services Holdings Limited (0.48%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

What does it mean to sell short Enzo Biochem stock?

Short selling ENZ is an investing strategy that aims to generate trading profit from Enzo Biochem as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Enzo Biochem?

A short squeeze for Enzo Biochem occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ENZ, which in turn drives the price of the stock up even further.

How often is Enzo Biochem's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENZ, twice per month. The most recent reporting period available is October, 15 2024.




This page (NYSE:ENZ) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners